It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
It is challenging to regenerate periodontal tissues fully. We have previously reported a heparan sulfate variant with enhanced affinity for bone morphogenetic protein-2, termed HS3, that enhanced periodontal tissue regeneration in a rodent model. Here we seek to transition this work closer to the clinic and investigate the efficacy of the combination HS3 collagen device in a non-human primate (NHP) periodontitis model. Wire-induced periodontitis was generated in ten Macaca fascicularis, and defects were treated with Emdogain or collagen (CollaPlug) loaded with (1) distilled water, (2) HS low (36 µg of HS3), or (3) HS high (180 µg of HS3) for 3 months. At the endpoint, microscopic assessment showed significantly less epithelial down-growth, greater alveolar bone filling, and enhanced cementum and periodontal ligament regeneration following treatment with the HS-collagen combination devices. When evaluated using a periodontal regeneration assessment score (PRAS) on a scale of 0–16, collagen scored 6.78 (± 2.64), Emdogain scored 10.50 (± 1.73) and HS low scored 10.40 (± 1.82). Notably, treatment with HS high scored 12.27 (± 2.20), while healthy control scored 14.80 (± 1.15). This study highlights the efficacy of an HS-collagen device for periodontal regeneration in a clinically relevant NHP periodontitis model and warrants its application in clinical trials.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243)
2 National Dental Research Institute Singapore, National Dental Centre Singapore, Singapore, Singapore (GRID:grid.418282.5) (ISNI:0000 0004 0620 9673); National University of Singapore, Duke-NUS Medical School, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
3 Bioprocessing Technology Institute, Agency for Science Technology and Research (A*STAR), Singapore, Singapore (GRID:grid.452198.3) (ISNI:0000 0004 0485 9218)
4 National Dental Research Institute Singapore, National Dental Centre Singapore, Singapore, Singapore (GRID:grid.418282.5) (ISNI:0000 0004 0620 9673)
5 Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243); The University of Queensland, School of Chemical Engineering, St Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)